Clinical Trial Update: A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LY4005130 in adults with non-segmental vitiligo is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo
• Vitiligo

Drugs mentioned

• LY4005130 (LY4005130)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 2 | Status: NOT_YET_RECRUITING